Charles River Laboratories International, Inc. (CRL)
NYSE: CRL · IEX Real-Time Price · USD
218.24
-0.34 (-0.16%)
At close: Jul 19, 2024, 4:00 PM
218.34
+0.10 (0.05%)
After-hours: Jul 20, 2024, 12:58 PM EDT
CRL Employees
Charles River Laboratories International had 21,800 employees as of December 31, 2023. The number of employees increased by 400 or 1.87% compared to the previous year.
Employees
21,800
Change (1Y)
400
Growth (1Y)
1.87%
Revenue / Employee
$188,605
Profits / Employee
$20,129
Market Cap
11.24B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 21,800 | 400 | 1.87% |
Dec 31, 2022 | 21,400 | 1,400 | 7.00% |
Dec 25, 2021 | 20,000 | 1,600 | 8.70% |
Dec 26, 2020 | 18,400 | 1,300 | 7.60% |
Dec 28, 2019 | 17,100 | 2,400 | 16.33% |
Dec 29, 2018 | 14,700 | 2,900 | 24.58% |
Dec 30, 2017 | 11,800 | 800 | 7.27% |
Dec 31, 2016 | 11,000 | 2,400 | 27.91% |
Dec 26, 2015 | 8,600 | 700 | 8.86% |
Dec 27, 2014 | 7,900 | 200 | 2.60% |
Dec 28, 2013 | 7,700 | 500 | 6.94% |
Dec 29, 2012 | 7,200 | 100 | 1.41% |
Dec 31, 2011 | 7,100 | -400 | -5.33% |
Dec 25, 2010 | 7,500 | -500 | -6.25% |
Dec 26, 2009 | 8,000 | -1,000 | -11.11% |
Dec 27, 2008 | 9,000 | 500 | 5.88% |
Dec 29, 2007 | 8,500 | 500 | 6.25% |
Dec 30, 2006 | 8,000 | -400 | -4.76% |
Dec 31, 2005 | 8,400 | 400 | 5.00% |
Dec 25, 2004 | 8,000 | 3,500 | 77.78% |
Dec 27, 2003 | 4,500 | -500 | -10.00% |
Dec 28, 2002 | 5,000 | 1,000 | 25.00% |
Dec 29, 2001 | 4,000 | 500 | 14.29% |
Dec 30, 2000 | 3,500 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Fresenius Medical Care AG & Co. KGaA | 119,845 |
Universal Health Services | 96,700 |
DaVita | 70,000 |
Smith & Nephew | 19,081 |
Catalent | 17,800 |
Teleflex | 14,500 |
Globus Medical | 5,000 |
Bio-Techne | 3,050 |
CRL News
- 5 days ago - Charles River Laboratories Schedules Second-Quarter 2024 Earnings Release and Conference Call - Business Wire
- 5 days ago - CRL INVESTIGATION ALERT: Johnson Fistel LLP Investigates Charles River Laboratories' Directors and Officers for Breach of Fiduciary Duties - GlobeNewsWire
- 14 days ago - Charles River to Perform Plasmid Manufacturing for AAVantgarde - Business Wire
- 27 days ago - Charles River Laboratories Announces Strategic Lentiviral Vector Manufacturing Collaboration with Gates Institute at University of Colorado Anschutz Medical Campus - Business Wire
- 5 weeks ago - Charles River and Captain T Cell Announce Plasmid DNA and Viral Vector Manufacturing Alliance for Gene-Modified Cell Therapy - Business Wire
- 5 weeks ago - Charles River Laboratories, in Collaboration With MatTek Corporation, Awarded Grant from the Foundation for Chemistry Research and Initiatives to Advance Research Alternatives - Business Wire
- 6 weeks ago - Charles River Laboratories Expands Access to CRADL® Contract Vivarium Space in Somerville - Business Wire
- 6 weeks ago - Charles River Laboratories Announces Development of Nonclinical Virtual Control Groups with Sanofi to Reduce the Use of Animals in Research - Business Wire